Pacific Biosciences
PACB
PACB
255 hedge funds and large institutions have $4.2B invested in Pacific Biosciences in 2021 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 87 increasing their positions, 79 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
3% more call options, than puts
Call options by funds: $21M | Put options by funds: $20.4M
1.87% less ownership
Funds ownership: 94.96% → 93.09% (-1.9%)
13% less capital invested
Capital invested by funds: $4.83B → $4.2B (-$629M)
Holders
255
Holding in Top 10
5
Calls
$21M
Puts
$20.4M
Top Buyers
| 1 | +$74.9M | |
| 2 | +$63.5M | |
| 3 | +$52.8M | |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$52.5M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$38M |
Top Sellers
| 1 | -$23.3M | |
| 2 | -$18M | |
| 3 | -$14.9M | |
| 4 |
SIG
Senator Investment Group
New York
|
-$14.1M |
| 5 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
-$11M |